Abstract:Abstract Background Recent data pointed that IBD is strictly related to gut microbiota although less is known about the connection between oral microbiota and IBD. It is also known that dysbiosis can lead to oral pathologies. Moreover, microbiome changes under therapeutic agents’ administration for IBD treatment have been described, including the identification of some bacteria as potential predictive markers for treatment effectiveness. The aim of our study was the quantification of salivary Firmicutes and Bacteroidetes in a cohort of IBD patients compared with a control group without IBD. Methods This was a collaborative transversal cohort study between an IBD consultation in a tertiary hospital and a faculty of dental medicine. Patients from IBD consultation were invited to participate and gave their informed consent. The exclusion criteria were the incapacity of mouth opening or give a written informed consent. Demographic and clinical data was collected. Oral health status was accessed to determine the periodontal diagnosis. Unstimulated saliva samples were collected before the oral examination for the quantification by quantitative real-time PCR. Statistical analysis was performed with SPSS 29.0 using Kruskal–Wallis H and Mann-Whitney U tests, and p values ≤ 0.05 were considered statistically significant. Results IBD patients presented an increased abundance of Firmicutes, both for UC (3.4 x10-5) and CD (4.9x10-5) as well as an increased abundance of Bacteroidetes for both UC (1.6 x10-5) and CD (1.4x10-5), when compared to the control group (figure 1). No significant differences were found between different treatments groups or no treatment (table 1) in abundance of Firmicutes and Bacteroidetes, respectively, of UC (p = 0.292 and p = 0.912) and CD (p=0.413 and p=0.254) patients. Additionally, no significant differences were found for Firmicutes and Bacteroidetes abundances, respectively, regarding: CD versus UC (p=0.600 and p=0.971), active disease and remission (based on a composite criterion for inactive disease considering HBI <5 for CD or a PMS ≤ 2 for UC, and FCP cut-off value of 150 mg/Kg), (p= 0.071 and p=0.242), smoking status (p=0.558 and p=0.488) and presence or absence of oral health (p=0.260 and p=0.556). Conclusion The oral microbiota characterization of IBD patients showed an elevated abundance of Firmicutes and Bacteroidetes when compared with healthy controls. These findings are valuable indicators of dysbiosis, emphasizing the intricate interplay between gut and oral microbiome in the context of inflammatory conditions. Future research is needed to clarify the oral-gut microbiome axis in IBD.

Changes in oral flora of patients with functional dyspepsia

Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth.

Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines

Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects

Study on the change of the level of plasma CCK before and after fatty diet in patients with functional dyspepsia (FD)

Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia

P1236 Oral microbiota dysbiosis in Inflammatory Bowel Disease patients

Decreased Basal and Postprandial Plasma 5-Hydroxytryptamine (5-HT) in Patients With Functional Dyspepsia (FD): A Pilot Study

Duodenal microbiota makes an important impact in functional dyspepsia

Alterations of gastric mucosal enterochromaffin cells in patients with postinfectious functional dyspepsia

Association between metabolic profile and microbiomic changes in rats with functional dyspepsia

High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease

The novel duodenal isolate Streptococcus salivarius AGIRA0003 promotes barrier dysfunction and IgG responses in functional dyspepsia

Decreased Basal and Postprandial Plasma Serotonin Levels in Patients with Functional Dyspepsia

Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease

Gastrointestinal Symptoms and Associated Factors in Chinese Patients with Functional Dyspepsia

Dysbiosis and Ecotypes of the Salivary Microbiome Associated with Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.

Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders

Mo1545 DISTINCT TREATMENT CHOICES BETWEEN PRIMARY CARE GI PHYSICIANS AND GENERAL RACTITIONERS: A REAL WORLD CROSS-SECTIONAL STUDY

Plase Lovels of Gastrointestinalhormones in Patients with Functional Dyspesia